PropertyValue
?:creator
?:doi
  • 10.1080/14712598.2020.1779217
?:doi
?:journal
  • Expert_opinion_on_biological_therapy
?:license
  • unk
?:pmid
?:pmid
  • 32510244
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era.
?:type
?:year
  • 2020-06-08

Metadata

Anon_0  
expand all